Vulnerability Description
European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.
CVSS Score
9.8
CRITICAL
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Echa.Europa | Iuclid | >= 5.15.0, < 6.27.6 |
Related Weaknesses (CWE)
References
- https://iuclid6.echa.europa.euProduct
- https://iuclid6.echa.europa.eu/documents/1387205/1809530/note_v6.27.6.pdf/76545aMitigationVendor Advisory
- https://iuclid6.echa.europa.eu/downloadProduct
- https://iuclid6.echa.europa.euProduct
- https://iuclid6.echa.europa.eu/documents/1387205/1809530/note_v6.27.6.pdf/76545aMitigationVendor Advisory
- https://iuclid6.echa.europa.eu/downloadProduct
FAQ
What is CVE-2023-26089?
CVE-2023-26089 is a vulnerability with a CVSS score of 9.8 (CRITICAL). European Chemicals Agency IUCLID 6.x before 6.27.6 allows authentication bypass because a weak hard-coded secret is used for JWT signing. The affected versions are 5.15.0 through 6.27.5.
How severe is CVE-2023-26089?
CVE-2023-26089 has been rated CRITICAL with a CVSS base score of 9.8/10. This is considered a critical vulnerability requiring immediate attention.
Is there a patch for CVE-2023-26089?
Check the references section above for vendor advisories and patch information. Affected products include: Echa.Europa Iuclid.